The effects of the dietary supplement Cardioflex on reducing cardiovascular disease risk factors in adults.

Heart disease and stroke are the leading causes of death and prescription drug use in Canada. In 2011, it was estimated that 1.6 million Canadians are living with heart disease or the effects of a stroke. One person every 7 minutes dies from heart disease or stroke in Canada. The purpose of this clinical trial is to take adults who are at risk for developing cardiovascular disease but are otherwise healthy and to determine whether daily supplementation with Cardioflex for 90 days will reduce their risk factor markers such as blood lipid (e.g. cholesterol and triglyceride).

Faculty Supervisor:

Semone Myrie

Student:

Trevor Kouritzin

Partner:

Innotech Nutrition

Discipline:

Food science

Sector:

Medical devices

University:

Program:

Accelerate

Related projects

Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.

View all
Current openings

Find the perfect opportunity to put your academic skills and knowledge into practice!

Find Projects

Mitacs Partners

The strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.

Government
Academic
Industry
Innovation

International

Load More

International

Load More

Join a thriving innovation ecosystem.

Subscribe to our newsletter now!

Subscribe
Canada